Private Management Group Inc. Sells 1,624,447 Shares of OraSure Technologies, Inc. $OSUR

Private Management Group Inc. cut its stake in OraSure Technologies, Inc. (NASDAQ:OSUR) by 30.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,797,682 shares of the medical instruments supplier’s stock after selling 1,624,447 shares during the period. Private Management Group Inc. owned 0.06% of OraSure Technologies worth $16,938,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of OSUR. Quadrature Capital Ltd purchased a new position in shares of OraSure Technologies in the fourth quarter worth $28,000. Legal & General Group Plc bought a new stake in OraSure Technologies in the 2nd quarter worth about $30,000. Prudential Financial Inc. purchased a new position in OraSure Technologies in the 2nd quarter worth about $31,000. Diversify Wealth Management LLC purchased a new position in OraSure Technologies in the 1st quarter worth about $36,000. Finally, Diversify Advisory Services LLC bought a new position in OraSure Technologies during the 2nd quarter valued at about $47,000. 93.50% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

OSUR has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of OraSure Technologies from a “sell” rating to a “hold” rating in a report on Monday, August 10th. Weiss Ratings upgraded shares of OraSure Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Reduce” and an average price target of $3.00.

OraSure Technologies Trading Down 2.4%

Shares of OSUR stock opened at $3.60 on Friday. OraSure Technologies, Inc. has a 12 month low of $2.08 and a 12 month high of $4.58. The stock has a market cap of $248.29 million, a P/E ratio of -5.22 and a beta of 1.00. The company has a 50 day simple moving average of $4.05 and a two-hundred day simple moving average of $3.54.

OraSure Technologies Profile

OraSure Technologies, Inc is a Bethlehem, Pennsylvania–based diagnostic and medical device company specializing in the development, manufacture and commercialization of point-of-care and self-testing products. Founded in 1988, OraSure has built a portfolio of oral fluid and other non-invasive specimen collection technologies that support the detection of infectious diseases, drugs of abuse, and health and wellness biomarkers.

The company’s flagship product, the OraQuick® rapid HIV test, was the first Food and Drug Administration–approved over-the-counter oral fluid test for the detection of HIV-1/2 antibodies.